Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,107 | 19,547 | 20,508 | 13,732 | 25,979 |
| Marketable Securities | 6,203 | 34,895 | 24,036 | 17,735 | N/A |
| Receivables | 15,807 | 12,539 | 10,892 | 10,700 | 9,671 |
| Inventories | 14,516 | 12,564 | 9,820 | 14,309 | 13,437 |
| Other current assets | 63,162 | 16,170 | 12,421 | 7,961 | 9,712 |
| TOTAL | $111,795 | $95,715 | $77,677 | $64,437 | $58,799 |
| Non-Current Assets | |||||
| PPE Net | 451,619 | 438,479 | 361,186 | 299,773 | 269,323 |
| TOTAL | $451,619 | $438,479 | $361,186 | $299,773 | $269,323 |
| Total Assets | $600,925 | $568,120 | $467,037 | $389,309 | $352,456 |
| Liabilities | |||||
| Current Liabilities | |||||
| TOTAL | $105,532 | $103,257 | $74,071 | $61,820 | $63,730 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 10,000 |
| Other Non-Current Liabilities | 1,193 | 1,309 | 1,371 | 1,411 | 1,329 |
| TOTAL | $1,193 | $1,309 | $1,371 | $1,411 | $11,329 |
| Total Liabilities | $176,631 | $163,486 | $114,982 | $89,177 | $95,926 |
| Shareholders' Equity | |||||
| Retained earnings | 248,284 | 202,253 | 154,723 | 112,446 | 79,007 |
| Other shareholders' equity | 176,010 | 202,381 | 197,332 | 187,686 | 177,523 |
| TOTAL | $424,294 | $404,634 | $352,055 | $300,132 | $256,530 |
| Total Liabilities And Equity | $600,925 | $568,120 | $467,037 | $389,309 | $352,456 |